Abstract
Energy metabolism in humans is tuned to distinct sex-specific functions that potentially reflect the unique requirements in females for gestation and lactation, whereas male metabolism may represent a default state. These differences are the consequence of the action of sex chromosomes and sex-specific hormones, including estrogens and progesterone in females and androgens in males. In humans, sex-specific specialization is associated with distinct body-fat distribution and energy substrate-utilization patterns; i.e., females store more lipids and have higher whole-body insulin sensitivity than males, while males tend to oxidize more lipids than females. These patterns are influenced by the menstrual phase in females, and by nutritional status and exercise intensity in both sexes. This minireview focuses on sex-specific mechanisms in lipid and glucose metabolism and their regulation by sex hormones, with a primary emphasis on studies in humans and the most relevant pre-clinical model of human physiology, non-human primates.
Introduction
While the role of sex in biology is undisputed, its consideration in research has been the subject of much recent debate. Although initial concerns were raised with the underrepresentation of women in clinical studies (1, 2), this issue also applies to pre-clinical research in many fields (3, 4). More recently, the National Institutes of Health is considering a proposal to require representation of both sexes in animal as well as cell-based studies (5, 6); in the latter instance, the effect of the sex of the source tissue, especially in the case of established cell lines, is not often considered (7). In parallel, a growing number of biomedical research journals are requiring specific clarification of the sex of animals and of the source tissue of cells used in published studies. In this context, it is timely to consider the sex-specific aspects of glucose and lipid metabolism in light of the disruption of these regulatory mechanisms in clinical pathologies such as metabolic syndrome, obesity, and diabetes. It is important to recall the distinction between sex, defined by chromosomal makeup, and gender, which is a social/cultural construct. Thus, in humans, sex differences arise from gene-dosage effects of the X and Y chromosomes (8, 9), which are elicited to a great extent through the actions of sex hormones. The effect of sex chromosomes themselves on metabolism has been clearly demonstrated by analyses of the four core genotypes mouse model that demonstrated that the sex chromosome complement controls adiposity, feeding behavior, fatty liver, and systemic glucose homeostasis (9), independent of gonadal sex. The mechanisms of sex differences in central nervous system (CNS) control of energy homeostasis in health and disease have been well summarized in several recent reviews (10–14).
Sex-Specific Differences in Fat Distribution
Women have higher percent body-fat (15, 16), less visceral white adipose tissue (V WAT), and more subcutaneous adipose tissue (SC WAT), both in the abdominal (17–20) and gluteofemoral (21, 22) regions. Various factors responsible for individual variability and sex differences in fat distribution have been described in detail in a recent review (23). Although body-mass index (BMI) is a strong predictor of overall mortality in humans (24), body-fat distribution is a stronger predictor of metabolic health. For example, low SC WAT is a favorable factor, whereas high V WAT is an unfavorable factor associated with altered lipid and glucose homeostasis (25–27). Furthermore, gluteal-femoral fat may have a protective effect against diabetes and overall mortality (28–30), suggesting that the effective compartmentalization of free fatty acids (FFAs) in low SC WAT may prevent abdominal obesity and associated metabolic disease (31). Regional differences in FFA metabolism do not fully explain sex-specific WAT distribution in humans, although a general trend in regional lipid utilization is consistent with the android and gynoid body types observed in males and females, respectively (25).
Sex-Specific Differences in Lipid Metabolism
Lipolysis
Under basal post-absorptive conditions, systemic FFA flux is similar in men and women (32), although upper-body SC WAT is more lipolytically active than lower-body SC WAT in both men and women [Figure 1; (32, 33)]. Non-oxidative FFA clearance through re-esterification, however, is higher in women than in men (34), suggesting that women tend to store, whereas men tend to oxidize, circulating FFAs (35). Men are less sensitive to the antilipolytic effects of insulin; i.e., the release of postprandial FFAs from upper-body SC WAT is less suppressed (more insulin-resistant) in men and FFA release from V WAT is less suppressed in women (32). This pattern of lipolysis is consistent with higher proportion of V WAT found in men (Figure 1). After a meal, systemic FFA flux is more suppressed by insulin in women (32), suggesting that women may have a higher risk of fat gain. Because the contribution of V WAT lipolysis to hepatic FFA delivery is greater in women, they are also more susceptible to hepatic insulin resistance (36, 37).
Figure 1
Sex- and depot-specific differences in lipid metabolism in humans. Women have higher percent body-fat and lower muscle mass and oxidize less lipid substrate than men. Women also have less V WAT and more SC WAT, both in the abdominal and gluteofemoral regions, than men. Outward arrows indicate basal (b) and insulin-inhibited (i) lipolysis. Inward arrows indicate basal (b) and insulin-stimulated (i) FFA uptake. Under basal post-absorptive conditions, upper-body SC WAT is more lipolytically active than lower-body SC WAT in both men and women (red outward arrows). The release of postprandial FFAs from upper-body SC WAT is less suppressed by insulin in men and FFA release from V WAT is less suppressed in women (green outward arrows). A greater percentage of postprandial FFAs are taken up by upper-body SC WAT in women than in men. Women display higher direct FFA uptake in leg SC WAT than men. Direct FFA uptake is higher in upper SC WAT than in lower SC WAT in men, but not in women. These sex differences in the topography of lipid metabolism may explain higher SC WAT, especially low-body SC WAT, in women compared to men. Higher muscle mass in males is beneficial for more efficient oxidation of FFAs.
FFA uptake and triglyceride storage
Although most lipid adsorption in human WAT tissue is mediated via hydrolysis of circulating triglycerides (TG) by lipoprotein lipase (LPL), it is now recognized that direct, LPL-independent FFA uptake may also contribute to lipid storage in humans (38, 39). A greater percentage of meal FFAs is stored (primarily by the LPL-dependent pathway) in upper SC WAT than in lower SC WAT in both men and women, but a greater percentage of dietary FFAs is stored in SC WAT in women than in men, who tend to store FFAs in V WAT [Figure 1; (35, 40)]. Interestingly, testosterone treatment increases the percentage of FFAs stored in SC WAT and decreases FFA storage in V WAT in middle-aged men (41). Basal FFA uptake and expression levels of FFA transporters are higher in upper SC WAT than in lower SC WAT in men, but not in women (38, 39). Women, however, display higher FFA uptake in leg SC WAT, which correlates with greater postprandial WAT LPL activity in women [Figure 1; (42)]. Furthermore, women have the highest rate of TG synthesis in their SC WAT compared to their visceral or any WAT depot in men (43). The menstrual cycle has no apparent effect on FFA tissue uptake in healthy women, consistent with studies in female non-human primates (NHPs) (35, 44).
Sex-Specific Differences in Glucose Metabolism and Insulin Action
Glucose metabolism in both sexes is highly responsive to physiological and nutritional states and physical fitness (45). During exercise, women oxidize more lipids and less carbohydrates, deplete less muscle glycogen, and exhibit lower hepatic glucose production (46, 47). At high altitude, women are able to attenuate the use of carbohydrates (48). This preferential substrate selection is attributed to estrogens (49). The potential mechanisms responsible for sex-specific metabolic responses to exercise include lower sympathetic nerve activity (50) and a greater type I and type II muscle fiber density (51) in women. Despite having a lower percentage of fat mass, the prevalence of type-2 diabetes and insulin resistance is higher in men (52–54). These differences are explained by higher whole-body insulin sensitivity in women (55–57). The human data are consistent with rodent studies that demonstrated greater insulin sensitivity and greater resistance to a high-fat diet (HFD) in females (58–61). The majority of human studies showed that glucose effectiveness and glucose appearance rates (62) are also higher in women (63–66).
The mechanisms responsible for sex differences in insulin sensitivity are not understood. One study reported no differences in insulin secretion between young males and young females (64), whereas others showed that females have higher first-phase insulin secretion than males (65). Sex differences in insulin signaling are tissue-specific, but have been primarily studied in rodent models (67). Kahn and colleagues reported that, in rodents, female WAT had a greater response to insulin and a greater increase in Akt and extracellular signal-related kinase (ERK) phosphorylation and lipogenesis than male WAT (61). Castration increased the insulin responsiveness of male WAT, while ovariectomy decreased insulin responsiveness of female WAT (61). Our studies in NHPs, however, suggest that, in contrast to rodents, testosterone promotes insulin-stimulated Akt phosphorylation and stimulates lipogenesis in WAT of castrated males (68). Greater rates of insulin-stimulated glucose uptake in female skeletal muscle and WAT correlate with higher expression levels of muscle mRNAs encoding glucose transporter-4 (Glut4) and metabolic enzymes (69).
Sex Hormones and Metabolism
Estrogens, progesterone, and menstrual cycle
The use of oral steroidal contraceptives is associated with a reduction in insulin sensitivity and low estrogen levels (70), suggesting that estrogens may protect females against insulin resistance. Consistent with this idea, studies in estrogen-deficient aromatase-knockout (ArKO) and ovariectomized wild-type mice showed that estrogen replacement can protect female mice against hepatic steatosis and improve mitochondrial β-oxidation (71) and insulin sensitivity (61, 72). The molecular mechanisms responsible for estrogen-mediated improvement in lipid-induced insulin resistance are tissue and pathway-specific and estrogen’s effects on various signal transduction and metabolic pathways in adipocytes, myocytes, and hepatocytes have been described in detail in a recent review (73).
Many anti-obesity effects of estrogens in mice are mediated by central mechanisms. Important regulators of metabolism have receptors in the CNS that mediate overall energy expenditure, food intake, glucose, and homeostasis (74). However, little is known about sex differences in CNS regulation of metabolism and most research has focused on estrogen action (75). The majority of estrogen’s anorexic action in the hypothalamus is mediated by estrogen receptor-α (ERα), and not estrogen receptor-β (ERβ) (76), although one study contested this notion (77). Diminished ERα activity is associated with obesity in both sexes. Estrogen-deficient androgen receptor (AR) knockout and ERα knockout male and female mice are obese and have decreased energy expenditure (78–80).
In addition to central mechanisms, estrogens can also directly suppress TG synthesis by reducing lipogenesis in the liver and increasing lipolysis in adipocytes (81–83). Estrogens potentiate lipid accumulation in SC WAT in males and females (84, 85), promote FFA β-oxidation, and reduce TG storage by stimulating the expression of peroxisome proliferation activator receptor-delta (PPARδ) and by activating AMP-activated protein kinase [AMPK; (81)]. In pancreas, estrogens exert protective effects on β-cell function by reducing amyloid formation in ovariectomized females (86) and obese males (87), and decrease β-cell injury induced by streptozotocin (STZ) in both sexes (88, 89). Interestingly, men lacking estrogen production or signaling because of mutations in the genes encoding aromatase or ERα are insulin-resistant and glucose-intolerant (90, 91), suggesting that estrogens may also regulate energy homeostasis in males. Although the beneficial effects of estrogens on whole-body glucose metabolism and insulin sensitivity have been demonstrated in several rodent models (73, 92), sex-specific effects in humans remain to be further elucidated.
Glucose metabolism is also affected by the menstrual phase, when the energy demand is high, which can be explained by the suppressive effect of estrogens and progesterone on gluconeogenesis (93). Estrogens promote insulin sensitivity, whereas progesterone promotes insulin resistance by antagonizing the positive effect of estrogens on contraction-stimulated glucose uptake (94) and increasing the activity of the β-oxidation pathway in skeletal muscle during exercise (95, 96). Glucose metabolism and exercise performance are influenced by the menstrual cycle phase in that glucose appearance and disappearance rates are higher during the follicular phase (high estrogen-to-progesterone ratio) compared to the luteal phase (high progesterone-to-estrogen ratio) (97). Muscle glycogen utilization depends on FFA availability in that there is an inverse correlation between FFA concentration and muscle glycogen use during exercise. The opposing actions of estrogens and progesterone on glycogen utilization may be mediated by their impact on FFA availability (98). Thus, glucose and lipid metabolism depends on the menstrual cycle phase, which determines the progesterone-to-estrogen ratio, and nutritional and exercise status.
Androgens
A significant portion of the world population suffers from various forms of metabolic abnormalities related to androgen imbalance, including hypoandrogenism in men (99–105) and hyperandrogenism in women (99, 106). Androgen deficiency in men is associated with insulin resistance and obesity, and treatment of hypogonadal men with testosterone improves insulin sensitivity and reduces fat content (99–105). In contrast, the androgen excess observed in women with polycystic ovary syndrome (PCOS) is associated with insulin resistance and obesity (99, 106).
Sex-dependent actions of androgens in WAT may explain differences in body-fat distribution (107) and insulin sensitivity in males and females (52, 54–56, 61). Aromatization of testosterone to 17β-estradiol is important for energy homeostasis, and an increased androgen-to-estrogen ratio promotes visceral obesity in males (108, 109). Men with genetic androgen resistance due to decreased AR expression develop visceral obesity (110), and AR knockout mice demonstrate higher visceral adiposity and insulin resistance (111, 112), suggesting that androgens may suppress WAT mass both in humans and rodents. Although human studies consistently demonstrate a positive correlation between hypogonadism, increased body-fat, and insulin resistance (99–105, 113, 114), it is unknown whether these changes represent direct effects of androgen imbalance on target tissues or secondary effects of aging or changes in lifestyle on whole-body metabolism and body composition.
For example, testosterone promotes the commitment of pluoropotent mesenchymal stem cells to the myogenic lineage (115), which may indirectly improve energy expenditure and accelerate fat mass loss, contributing to improved insulin sensitivity in testosterone-supplemented males. Testosterone increases the expression of the transcription factor PGC1α in skeletal muscle (116), stimulating mitochondrial biogenesis, substrate oxidation, and muscle insulin sensitivity. Lower levels of PGC1α are found in insulin-resistant type-2 diabetic patients (117). In rodents, testosterone exerts gender-specific protective effects against STZ-induced apoptosis of male β-cells (118, 119). Interestingly, androgen administration to normally STZ-resistant female rats make them highly susceptible to β-cell death (88). Thus, in rodents testosterone is involved in a gender-specific regulation of β-cell number, playing a protective antidiabetic role in males, but can override the protective role of estrogens in females, illustrating the importance of the androgen/estrogen ratio in β-cell survival in females.
Sex-Specific Effects in NHPs
Consistent with human studies, female rhesus macaques exhibit significantly higher levels of insulin-stimulated glucose disposal than males (120) and estrogens can improve glucose regulation in female macaques (121). In contrast to estrogen effects, adult female rhesus macaques exposed to androgens developed insulin resistance, although this effect was only apparent in animals consuming a HFD (44). Studies in prenatally androgenized monkeys further demonstrated that androgens disrupt insulin sensitivity and glucoregulation in female offspring (122, 123). These findings are consistent with the idea that exposure of females to androgens may trigger a metabolic reprograming toward a male-like phenotype.
Androgen effects in adult female NHPs are menstrual cycle-dependent, in that V WAT lipolysis and hormone-sensitive lipase (HSL) expression were upregulated during the luteal phase compared with the early follicular phase of the ovarian cycle, while hyperandrogenemia attenuated lipolysis and HSL expression during the luteal phase but not during menses (44). Insulin sensitivity of FFA uptake in WAT was also differentially affected by testosterone in a menstrual cycle-dependent manner (44). Collectively, these findings may explain the predisposition of women with PCOS to WAT dysfunction and obesity (99, 106). Androgen supplementation studies in adult male rhesus macaques suggest that androgens do not control whole-body insulin sensitivity, at least under conditions of a low-fat (chow) diet (68, 124), but a lack of testosterone can have a negative impact on WAT biogenesis and function (68). Prenatally androgenized male rhesus macaques, however, develop insulin resistance, suggesting that early exposure to androgens may cause fetal reprograming of male metabolic tissues (125). Interestingly, testosterone stimulates WAT lipogenic gene expression in both males and females (44, 68), suggesting that androgens can facilitate maturation of WAT in both sexes.
Conclusion
Overall, female lipid metabolism functions to store more fat in SC WAT, with a higher proportion of lipids deposited in lower body-fat, while men store more lipids in V WAT than in SC WAT and oxidize dietary FFAs more readily than women. These differences presumably reflect the opposite sex-specific specialization in energy utilization, with women having the unique burden of gestation and lactation. Higher insulin sensitivity and lower muscle mass observed in women is more beneficial for energy storage in WAT and less beneficial for its oxidation. Furthermore, more efficient insulin inhibition of lipolysis facilitates greater TG retention in female WAT than in male WAT. Estrogens and androgens exert beneficial metabolic effects by lowering body-fat and improving insulin sensitivity in females and males, respectively, although the role of androgens in regulating insulin action in humans, especially under conditions of different diets, remains controversial. The use of NHP models may help separate the direct effects of sex hormones on metabolic tissues from indirect effects, such as the differences in lifestyle, diet, and prior medical history observed in human patients.
Statements
Acknowledgments
This work was supported by NIH grants R21 AG047543 (Oleg Varlamov), R01 MH86542 (Cynthia L. Bethea), P50 HD071836 (Charles T. Roberts Jr.), and P51 OD011092 for operation of the Oregon National Primate Research Center.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
I.O.M. Sex Differences and Implications for Translational Neuroscience Research: Workshop Summary. Washington, DC: The National Academies Press (2011).
2
I.O.M. Sex-Specific Reporting of Scientific Research: A Workshop Summary. Washington, DC: The National Academies Press (2012).
3
BeeryAKZuckerI. Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev (2011) 35:565–72.10.1016/j.neubiorev.2010.07.002
4
WoodruffTKKibbeMRPallerASTurekFWWoolleyCS. Commentary: “Leaning in” to support sex differences in basic science and clinical research. Endocrinology (2014) 155:1181–3.10.1210/en.2014-1068
5
ClaytonJACollinsFS. Policy: NIH to balance sex in cell and animal studies. Nature (2014) 509:282–3.10.1038/509282a
6
DanskaJS. Sex matters for mechanism. Sci Transl Med (2014) 6:258fs240.10.1126/scitranslmed.3009859
7
FullerCMInselPA. I don’t know the question, but sex is definitely the answer! Focus on “In pursuit of scientific excellence: sex matters” and “Do you know the sex of your cells?Am J Physiol Cell Physiol (2014) 306:C1–2.10.1152/ajpcell.00342.2013
8
ChenXMcCluskyRItohYReueKArnoldAP. X and Y chromosome complement influence adiposity and metabolism in mice. Endocrinology (2013) 154:1092–104.10.1210/en.2012-2098
9
LinkJCChenXArnoldAPReueK. Metabolic impact of sex chromosomes. Adipocyte (2013) 2:74–9.10.4161/adip.23320
10
ShiHStraderADSorrellJEChambersJBWoodsSCSeeleyRJ. Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis. Am J Physiol Endocrinol Metab (2008) 294:E630–9.10.1152/ajpendo.00704.2007
11
LovejoyJCSainsburyA. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev (2009) 10:154–67.10.1111/j.1467-789X.2008.00529.x
12
ShiHCleggDJ. Sex differences in the regulation of body weight. Physiol Behav (2009) 97:199–204.10.1016/j.physbeh.2009.02.017
13
ArnetzLEkbergNRAlvarssonM. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes (2014) 7:409–20.10.2147/DMSO.S51301
14
HendersonGC. Sexual dimorphism in the effects of exercise on metabolism of lipids to support resting metabolism. Front Endocrinol (Lausanne) (2014) 5:162.10.3389/fendo.2014.00162
15
WomersleyJ. A comparison of the skinfold method with extent of ‘overweight’ and various weight-height relationships in the assessment of obesity. Br J Nutr (1977) 38:271–84.10.1079/BJN19770088
16
JacksonASStanforthPRGagnonJRankinenTLeonASRaoDCet alThe effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. Int J Obes Relat Metab Disord (2002) 26:789–96.10.1038/sj.ijo.0802006
17
SchreinerPJTerryJGEvansGWHinsonWHCrouseJRIIIHeissG. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol (1996) 144:335–45.10.1093/oxfordjournals.aje.a008934
18
DespresJPCouillardCGagnonJBergeronJLeonASRaoDCet alRace, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol (2000) 20:1932–8.10.1161/01.ATV.20.8.1932
19
DemerathEWSunSSRogersNLeeMReedDChohACet alAnatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) (2007) 15:2984–93.10.1038/oby.2007.356
20
CamhiSMBrayGABouchardCGreenwayFLJohnsonWDNewtonRLet alThe relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) (2011) 19:402–8.10.1038/oby.2010.248
21
GoodpasterBHKrishnaswamiSHarrisTBKatsiarasAKritchevskySBSimonsickEMet alObesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med (2005) 165:777–83.10.1001/archinte.165.7.777
22
YimJEHeshkaSAlbuJBHeymsfieldSGallagherD. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol (1985) (2008) 104:700–7.10.1152/japplphysiol.01035.2007
23
KarastergiouKSmithSRGreenbergASFriedSK. Sex differences in human adipose tissues – the biology of pear shape. Biol Sex Differ (2012) 3:13.10.1186/2042-6410-3-13
24
WhitlockGLewingtonSSherlikerPClarkeREmbersonJHalseyJet alBody-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 373:1083–96.10.1016/S0140-6736(09)60318-4
25
VagueJ. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr (1956) 4:20–34.
26
SnijderMBVisserMDekkerJMGoodpasterBHHarrisTBKritchevskySBet alLow subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia (2005) 48:301–8.10.1007/s00125-004-1637-7
27
BluherM. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol (2010) 21:38–43.10.1097/MOL.0b013e3283346ccc
28
FolsomARKayeSASellersTAHongCPCerhanJRPotterJDet alBody fat distribution and 5-year risk of death in older women. JAMA (1993) 269:483–7.10.1001/jama.269.4.483
29
CareyVJWaltersEEColditzGASolomonCGWillettWCRosnerBAet alBody fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol (1997) 145:614–9.10.1093/oxfordjournals.aje.a009158
30
PischonTBoeingHHoffmannKBergmannMSchulzeMBOvervadKet alGeneral and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 359:2105–20.10.1056/NEJMoa0801891
31
HernandezTLKittelsonJMLawCKKetchLLStobNRLindstromRCet alFat redistribution following suction lipectomy: defense of body fat and patterns of restoration. Obesity (Silver Spring) (2011) 19:1388–95.10.1038/oby.2011.64
32
JensenMD. Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest (1995) 96:2297–303.10.1172/JCI118285
33
MartinMLJensenMD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest (1991) 88:609–13.10.1172/JCI115345
34
NielsenSGuoZAlbuJBKleinSO’BrienPCJensenMD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 111:981–8.10.1172/JCI16253
35
UrangaAPLevineJJensenM. Isotope tracer measures of meal fatty acid metabolism: reproducibility and effects of the menstrual cycle. Am J Physiol Endocrinol Metab (2005) 288:E547–55.10.1152/ajpendo.00340.2004
36
MiyazakiYGlassLTriplittCWajcbergEMandarinoLJDefronzoRA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2002) 283:E1135–43.10.1152/ajpendo.00327.2001
37
NielsenSGuoZJohnsonCMHensrudDDJensenMD. Splanchnic lipolysis in human obesity. J Clin Invest (2004) 113:1582–8.10.1172/JCI21047
38
BickertonASRobertsRFieldingBAHodsonLBlaakEEWagenmakersAJet alPreferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes (2007) 56:168–76.10.2337/db06-0822
39
ShadidSKoutsariCJensenMD. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes (2007) 56:1369–75.10.2337/db06-1680
40
RomanskiSANelsonRMJensenMD. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab (2000) 279:E455–62.
41
MarinPLonnLAnderssonBOdenBOlbeLBengtssonBAet alAssimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab (1996) 81:1018–22.10.1210/jcem.81.3.8772568
42
VotrubaSBJensenMD. Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am J Physiol Endocrinol Metab (2006) 291:E1115–23.10.1152/ajpendo.00196.2006
43
EdensNKFriedSKKralJGHirschJLeibelRL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol (1993) 265:E374–9.
44
VarlamovOChuMPMcGeeWKCameronJLO’RourkeRWMeyerKAet alOvarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates. Endocrinology (2013) 154:4126–35.10.1210/en.2013-1428
45
TarnopolskyMARubyBC. Sex differences in carbohydrate metabolism. Curr Opin Clin Nutr Metab Care (2001) 4:521–6.10.1097/00075197-200111000-00010
46
McKenzieSPhillipsSMCarterSLLowtherSGibalaMJTarnopolskyMA. Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans. Am J Physiol Endocrinol Metab (2000) 278:E580–7.
47
CarterSLRennieCTarnopolskyMA. Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab (2001) 280:E898–907.
48
BraunBMawsonJTMuzaSRDominickSBBrooksGAHorningMAet alWomen at altitude: carbohydrate utilization during exercise at 4,300 m. J Appl Physiol (1985) (2000) 88:246–56.
49
CarterSMcKenzieSMourtzakisMMahoneyDJTarnopolskyMA. Short-term 17beta-estradiol decreases glucose R(a) but not whole body metabolism during endurance exercise. J Appl Physiol (1985) (2001) 90:139–46.
50
JonesPPSnitkerSSkinnerJSRavussinE. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol (1996) 270:E363–6.
51
SimoneauJABouchardC. Human variation in skeletal muscle fiber-type proportion and enzyme activities. Am J Physiol (1989) 257:E567–72.
52
FriasJPMacaraegGBOfrecioJYuJGOlefskyJMKruszynskaYT. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes (2001) 50:1344–50.10.2337/diabetes.50.6.1344
53
KuhlJHildingAOstensonCGGrillVEfendicSBavenholmP. Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm diabetes prevention programme: the impact of sex and type 2 diabetes heredity. Diabetologia (2005) 48:35–40.10.1007/s00125-004-1614-1
54
SoetersMRSauerweinHPGroenerJEAertsJMAckermansMTGlatzJFet alGender-related differences in the metabolic response to fasting. J Clin Endocrinol Metab (2007) 92:3646–52.10.1210/jc.2007-0552
55
BoynsDRCrossleyJNAbramsMEJarrettRJKeenH. Oral glucose tolerance and related factors in a normal population sample. I. Blood sugar, plasma insulin, glyceride, and cholesterol measurements and the effects of age and sex. Br Med J (1969) 1:595–8.10.1136/bmj.1.5644.595
56
Yki-JarvinenH. Sex and insulin sensitivity. Metabolism (1984) 33:1011–5.10.1016/0026-0495(84)90229-4
57
NuutilaPKnuutiMJMakiMLaineHRuotsalainenUTerasMet alGender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes (1995) 44:31–6.10.2337/diab.44.1.31
58
ZierathJRHouseknechtKLGnudiLKahnBB. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes (1997) 46:215–23.10.2337/diabetes.46.2.215
59
CorsettiJPSparksJDPetersonRGSmithRLSparksCE. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis (2000) 148:231–41.10.1016/S0021-9150(99)00265-8
60
TrevaskisJLMeyerEAGalganiJEButlerAA. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice. Endocrinology (2008) 149:174–84.10.1210/en.2007-0868
61
MacotelaYBoucherJTranTTKahnCR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes (2009) 58:803–12.10.2337/db08-1054
62
BestJDKahnSEAderMWatanabeRMNiTCBergmanRN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care (1996) 19:1018–30.10.2337/diacare.19.9.1018
63
HalePJWrightJVNattrassM. Differences in insulin sensitivity between normal men and women. Metabolism (1985) 34:1133–8.10.1016/0026-0495(85)90159-3
64
BasuRDalla ManCCampioniMBasuAKleeGToffoloGet alEffects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes (2006) 55:2001–14.10.2337/db05-1692
65
FlanaganDEHoltRIOwensPCCockingtonRJMooreVMRobinsonJSet alGender differences in the insulin-like growth factor axis response to a glucose load. Acta Physiol (Oxf) (2006) 187:371–8.10.1111/j.1748-1716.2006.01581.x
66
BockGDalla ManCCampioniMChittilapillyEBasuRToffoloGet alEffects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes (2007) 56:1113–9.10.2337/db06-1272
67
MayesJSWatsonGH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev (2004) 5:197–216.10.1111/j.1467-789X.2004.00152.x
68
VarlamovOWhiteAECarrollJMBetheaCLReddyASlaydenOet alAndrogen effects on adipose tissue architecture and function in nonhuman primates. Endocrinology (2012) 153:3100–10.10.1210/en.2011-2111
69
RuneASalehzadehFSzekeresFKuhnIOslerMEAl-KhaliliL. Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women. Acta Physiol (Oxf) (2009) 197:207–15.10.1111/j.1748-1716.2009.02010.x
70
PerseghinGScifoPPagliatoEBattezzatiABenediniSSoldiniLet alGender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab (2001) 86:3188–96.10.1210/jcem.86.7.7666
71
NemotoYTodaKOnoMFujikawa-AdachiKSaibaraTOnishiSet alAltered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest (2000) 105:1819–25.10.1172/JCI9575
72
CamporezJPJornayvazFRLeeHYKandaSGuigniBAKahnMet alCellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology (2013) 154:1021–8.10.1210/en.2012-1989
73
JelenikTRodenM. How estrogens prevent from lipid-induced insulin resistance. Endocrinology (2013) 154:989–92.10.1210/en.2013-1112
74
XuYNedungadiTPZhuLSobhaniNIraniBGDavisKEet alDistinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab (2011) 14:453–65.10.1016/j.cmet.2011.08.009
75
CleggDJ. Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol (2012) 26:1957–60.10.1210/me.2012-1284
76
GearyNAsarianLKorachKSPfaffDWOgawaS. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology (2001) 142:4751–7.10.1210/endo.142.11.8504
77
LiangYQAkishitaMKimSAkoJHashimotoMIijimaKet alEstrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord (2002) 26:1103–9.10.1038/sj.ijo.0802054
78
HeinePATaylorJAIwamotoGALubahnDBCookePS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 97:12729–34.10.1073/pnas.97.23.12729
79
JonesMEThorburnAWBrittKLHewittKNWrefordNGProiettoJet alAromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A (2000) 97:12735–40.10.1073/pnas.97.23.12735
80
RibasVNguyenMTHenstridgeDCNguyenAKBeavenSWWattMJet alImpaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab (2010) 298:E304–19.10.1152/ajpendo.00504.2009
81
D’EonTMSouzaSCAronovitzMObinMSFriedSKGreenbergAS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem (2005) 280:35983–91.10.1074/jbc.M507339200
82
GaoHBryzgalovaGHedmanEKhanAEfendicSGustafssonJAet alLong-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol Endocrinol (2006) 20:1287–99.10.1210/me.2006-0012
83
BryzgalovaGLundholmLPortwoodNGustafssonJAKhanAEfendicSet alMechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab (2008) 295:E904–12.10.1152/ajpendo.90248.2008
84
CookePSNaazA. Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) (2004) 229:1127–35.
85
CleggDJBrownLMWoodsSCBenoitSC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes (2006) 55:978–87.10.2337/diabetes.55.04.06.db05-1339
86
KahnSEAndrikopoulosSVerchereCBWangFHullRLVidalJ. Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes. Diabetologia (2000) 43:1309–12.10.1007/s001250051527
87
GeislerJGZawalichWZawalichKLakeyJRStukenbrokHMiliciAJet alEstrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes (2002) 51:2158–69.10.2337/diabetes.51.7.2158
88
PaikSGMichelisMAKimYTShinS. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes (1982) 31:724–9.10.2337/diab.31.8.724
89
Le MayCChuKHuMOrtegaCSSimpsonERKorachKSet alEstrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A (2006) 103:9232–7.10.1073/pnas.0602956103
90
SmithEPBoydJFrankGRTakahashiHCohenRMSpeckerBet alEstrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 331:1056–61.10.1056/NEJM199410203311604
91
MorishimaAGrumbachMMSimpsonERFisherCQinK. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab (1995) 80:3689–98.10.1210/jcem.80.12.8530621
92
Mauvais-JarvisF. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab (2011) 22:24–33.10.1016/j.tem.2010.10.002
93
MatuteMLKalkhoffRK. Sex steroid influence on hepatic gluconeogenesis and glucogen formation. Endocrinology (1973) 92:762–8.10.1210/endo-92-3-762
94
CampbellSEFebbraioMA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab (2002) 282:E1139–46.10.1152/ajpendo.00184.2001
95
HattaHAtomiYShinoharaSYamamotoYYamadaS. The effects of ovarian hormones on glucose and fatty acid oxidation during exercise in female ovariectomized rats. Horm Metab Res (1988) 20:609–11.10.1055/s-2007-1010897
96
CampbellSEFebbraioMA. Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab (2001) 281:E803–8.
97
CampbellSEAngusDJFebbraioMA. Glucose kinetics and exercise performance during phases of the menstrual cycle: effect of glucose ingestion. Am J Physiol Endocrinol Metab (2001) 281:E817–25.
98
D’EonTMSharoffCChipkinSRGrowDRubyBCBraunB. Regulation of exercise carbohydrate metabolism by estrogen and progesterone in women. Am J Physiol Endocrinol Metab (2002) 283:E1046–55.10.1152/ajpendo.00271.2002
99
DingELSongYMalikVSLiuS. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2006) 295:1288–99.10.1001/jama.295.11.1288
100
TurgeonJLCarrMCMakiPMMendelsohnMEWisePM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev (2006) 27:575–605.10.1210/er.2005-0020
101
SelvinEFeinleibMZhangLRohrmannSRifaiNNelsonWGet alAndrogens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2007) 30:234–8.10.2337/dc06-1579
102
TraishAMGuayAFeeleyRSaadF. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl (2009) 30:10–22.10.2164/jandrol.108.005215
103
DhindsaSMillerMGMcWhirterCLMagerDEGhanimHChaudhuriAet alTestosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care (2010) 33:1186–92.10.2337/dc09-1649
104
GrossmannMGianattiEJZajacJD. Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes (2010) 17:247–56.10.1097/MED.0b013e32833919cf
105
LiCFordESLiBGilesWHLiuS. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care (2010) 33:1618–24.10.2337/dc09-1788
106
CorbouldA. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?Diabetes Metab Res Rev (2008) 24:520–32.10.1002/dmrr.872
107
NedungadiTPCleggDJ. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res (2009) 2:321–7.10.1007/s12265-009-9101-1
108
McInnesKJCorbouldASimpsonERJonesME. Regulation of adenosine 5’, monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state. Endocrinology (2006) 147:5907–13.10.1210/en.2006-0879
109
Moverare-SkrticSVenkenKAnderssonNLindbergMKSvenssonJSwansonCet alDihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring) (2006) 14:662–72.10.1038/oby.2006.75
110
ZitzmannMGromollJVon EckardsteinANieschlagE. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia (2003) 46:31–9.10.1007/s00125-002-0980-9
111
FanWYanaseTNomuraMOkabeTGotoKSatoTet alAndrogen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes (2005) 54:1000–8.10.2337/diabetes.54.4.1000
112
LinHYXuQYehSWangRSSparksJDChangC. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes (2005) 54:1717–25.10.2337/diabetes.54.6.1717
113
KatznelsonLFinkelsteinJSSchoenfeldDARosenthalDIAndersonEJKlibanskiA. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 81:4358–65.10.1210/jcem.81.12.8954042
114
MaurasNHayesVWelchSRiniAHelgesonKDoklerMet alTestosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab (1998) 83:1886–92.10.1210/jcem.83.6.4892
115
SinghRArtazaJNTaylorWEGonzalez-CadavidNFBhasinS. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology (2003) 144:5081–8.10.1210/en.2003-0741
116
PitteloudNMoothaVKDwyerAAHardinMLeeHErikssonKFet alRelationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care (2005) 28:1636–42.10.2337/diacare.28.7.1636
117
MoothaVKLindgrenCMErikssonKFSubramanianASihagSLeharJet alPGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 34:267–73.10.1038/ng1180
118
MorimotoSMendoza-RodriguezCAHiriartMLarrietaMEVitalPCerbonMA. Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas. J Endocrinol (2005) 187:217–24.10.1677/joe.1.06357
119
Palomar-MoralesMMorimotoSMendoza-RodriguezCACerbonMA. The protective effect of testosterone on streptozotocin-induced apoptosis in beta cells is sex specific. Pancreas (2010) 39:193–200.10.1097/MPA.0b013e3181c156d9
120
RamseyJJLaatschJLKemnitzJW. Age and gender differences in body composition, energy expenditure, and glucoregulation of adult rhesus monkeys. J Med Primatol (2000) 29:11–9.10.1034/j.1600-0684.2000.290102.x
121
KemnitzJWGibberJRLindsayKAEiseleSG. Effects of ovarian hormones on eating behaviors, body weight, and glucoregulation in rhesus monkeys. Horm Behav (1989) 23:235–50.10.1016/0018-506X(89)90064-0
122
EisnerJRDumesicDAKemnitzJWAbbottDH. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab (2000) 85:1206–10.10.1210/jcem.85.3.6453
123
AbbottDHBrunsCRBarnettDKDunaifAGoodfriendTLDumesicDAet alExperimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am J Physiol Endocrinol Metab (2010) 299:E741–51.10.1152/ajpendo.00058.2010
124
BilliarRBRichardsonDSchwartzRPosnerBLittleB. Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. Am J Obstet Gynecol (1987) 157:1297–302.10.1016/S0002-9378(87)80319-8
125
BrunsCMBaumSTColmanRJEisnerJRKemnitzJWWeindruchRet alInsulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab (2004) 89:6218–23.10.1210/jc.2004-0918
Summary
Keywords
adipose tissue, androgens, estrogens, fatty acid, insulin sensitivity, obesity, sex differences
Citation
Varlamov O, Bethea CL and Roberts CT Jr. (2015) Sex-Specific Differences in Lipid and Glucose Metabolism. Front. Endocrinol. 5:241. doi: 10.3389/fendo.2014.00241
Received
05 November 2014
Accepted
19 December 2014
Published
19 January 2015
Volume
5 - 2014
Edited by
Janne Lebeck, Danish Diabetes Academy, Denmark
Reviewed by
Shinichi Oikawa, Nippon Medical School, Japan; Zhong Q. Wang, Pennington Biomedical Research Center, USA
Copyright
© 2015 Varlamov, Bethea and Roberts.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Oleg Varlamov, Divisions of Diabetes, Obesity, and Metabolism and Developmental and Reproductive Sciences, Oregon National Primate Research Center, 505 NW 185th Avenue, Beaverton, OR 97006, USA e-mail: varlamov@ohsu.edu
This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.